Atazanavir and HIV Drug Resistance: Understanding the Risks
- Apr, 27 2023
- 0
As a copywriter, I've been researching Atazanavir and its role in HIV drug resistance. It turns out that Atazanavir is a protease inhibitor used in the treatment of HIV, and while it's effective, there are risks of drug resistance developing. This can happen when the virus mutates and becomes less susceptible to the medication. Factors such as poor adherence to the treatment regimen and previous exposure to other HIV drugs can increase the risk of resistance. Therefore, it's crucial for patients and healthcare providers to closely monitor and manage these risks to ensure the continued effectiveness of Atazanavir in HIV treatment.